A new 'gold standard' clinical trial shows that epilepsy drug Sulthiame could vastly reduce Obstructive Sleep Apnea symptoms.
A European epilepsy drug could be an effective treatment for sleep apnea, a new study suggests ... the nutritional supplement lithium asparate may not ease the fatigue and brain fog of Long ...
Sulthiame, an epilepsy drug sold under the brand name Ospolot in Europe, appeared to reduce symptoms of obstructive sleep apnea (OSA) in a late-breaking clinical trial presented at the European ...
A new dose-finding study supported the potential of the carbonic anhydrase inhibitor as an alternative to CPAP machines.
Using the apnea-hypopnea index of AHI3a, which assesses breathing interruptions during sleep, the researchers found that patients on the highest dose of sulthiame had 39.9% lower frequency of ...
An epilepsy drug could help ... Sulthiame, a drug sold under the brand name Ospolot, appeared to reduce symptoms of obstructive sleep apnoea in a recent international clinical trial of 298 patients.
Patients taking sulthiame, a drug currently in use for epilepsy, experienced a reduction in their symptoms of obstructive sleep apnea (OSA ... and they may wake up several times.
30, 2023 — Slow waves that usually only occur in the brain during sleep ... For Epilepsy, Yoga May Be Good for Your Mind Nov. 8, 2023 — For people with epilepsy, doing yoga may help reduce ...
WASHINGTON (dpa-AFX) - A recent study presented at the European Respiratory Society Congress has suggested that the epilepsy ... may offer relief for individuals suffering from obstructive sleep ...
A European epilepsy drug could be an effective treatment for sleep apnea, a new study suggests. Patients who took sulthiame had few pauses in their breathing while asleep, as well as higher levels ...
